Crossject Share Price
Stocks
ALCJ
FR0011716265
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Euronext Paris
13:49:37 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.298 EUR | -0.76% |
|
-0.61% | -40.73% |
| 10-12 | Crossject: No market launch of Zepizure before H127 at best | AL |
| 09-25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
| Market Cap | 71.21M 79.92M 65.93M 59.67M 112M 7.54B 114M 790M 310M 3.96B 300M 294M 12.63B | P/E 2026 * |
3.19x | P/E 2027 * | 2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 53.31M 59.83M 49.36M 44.67M 84.16M 5.65B 85.15M 592M 232M 2.97B 224M 220M 9.46B | EV / Sales 2026 * |
0.88x | EV / Sales 2027 * | 0.37x |
| Free-Float |
92.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCJ | Real-time | |
Tradegate
| 74C | Real-time | |
|
Boerse Muenchen
| 74C | Real-time | |
|
Börse Stuttgart
| 74C | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 74C | Delayed | |
|
CBOE
| Real-time |
| 1 day | -0.76% | ||
| 1 week | -0.61% | ||
| Current month | -5.94% | ||
| 1 month | -3.85% | ||
| 3 months | -15.93% | ||
| 6 months | -35.10% | ||
| Current year | -40.73% |
| 1 week | 1.23 |  | 1.32 |
| 1 month | 1.1 | | 1.44 |
| Current year | 1.1 | | 2.58 |
| 1 year | 1.1 | | 2.7 |
| 3 years | 0.72 | | 5.96 |
| 5 years | 0.72 | | 5.96 |
| 10 years | 0.72 | | 7.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 07/08/2001 | |
Lionel Seltz
DFI | Director of Finance/CFO | - | 24/03/2026 |
Tony C. Tipton
PRN | Corporate Officer/Principal | - | 19/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Monnot
CHM | Chairman | 67 | 25/06/2009 |
Eric Nemeth
BRD | Director/Board Member | 67 | - |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/07/25 | Buy | Director | 13,386 | 0.0266% | ||
| 01/07/25 | Buy | Director | 50 | 0.0001% | ||
| 01/07/25 | Buy | Director | 337 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -0.61% | -46.14% | -66.80% | 79.92M | |
| -1.89% | -2.39% | -21.19% | +3.85% | 174B | |
| -2.23% | +5.67% | -21.63% | +12.01% | 114B | |
| -1.69% | -1.27% | -2.92% | +27.96% | 114B | |
| +0.95% | +17.99% | -43.66% | +6.01% | 89.64B | |
| -0.83% | +1.27% | +3.53% | +80.36% | 64.96B | |
| -0.47% | +5.71% | +14.57% | +81.93% | 56.09B | |
| +0.28% | +2.89% | +2.81% | -24.86% | 52.94B | |
| -0.80% | +4.63% | -13.13% | +29.62% | 43.6B | |
| +0.59% | +1.89% | -7.81% | -13.39% | 32.77B | |
| Average | +0.36% | +3.91% | -13.56% | +13.67% | 74.2B | |
| Weighted average by Cap. | +0.61% | +3.58% | -13.53% | +20.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.8M 68.23M 56.29M 50.94M 95.97M 6.44B 97.11M 675M 265M 3.38B 256M 251M 10.78B | 65.2M 73.17M 60.36M 54.63M 103M 6.9B 104M 724M 284M 3.63B 274M 269M 11.57B |
| Net income | 6.6M 7.41M 6.11M 5.53M 10.42M 699M 10.54M 73.26M 28.75M 367M 27.78M 27.21M 1.17B | 8.6M 9.65M 7.96M 7.21M 13.58M 911M 13.74M 95.46M 37.46M 479M 36.2M 35.45M 1.53B |
| Net Debt | -17.9M -20.09M -16.57M -15M -28.26M -1.9B -28.59M -199M -77.97M -996M -75.35M -73.79M -3.18B | -47M -52.74M -43.51M -39.38M -74.19M -4.98B -75.07M -522M -205M -2.62B -198M -194M -8.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | €1.298 | -0.76% | 73,426 |
| 21/10/26 | €1.308 | +0.77% | 82,662 |
| 20/10/26 | €1.298 | +3.51% | 118,314 |
| 19/10/26 | €1.254 | -0.95% | 142,708 |
| 16/10/26 | €1.266 | -3.06% | 62,499 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALCJ Stock
Select your edition
All financial news and data tailored to specific country editions
